PRESS RELEASE published on 03/14/2024 at 07:30, 8 months 7 days ago Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business Dermapharm Holding SE reaches upper end of adjusted EBITDA guidance range by achieving 10.8% revenue growth in 2023, proposes a dividend of EUR 0.88 per share for the year Financial Results Adjusted EBITDA Revenue Growth Dividend Proposal Dermapharm Holding SE
PRESS RELEASE published on 08/29/2023 at 07:30, 1 year 2 months ago Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
PRESS RELEASE published on 08/16/2023 at 07:30, 1 year 3 months ago Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
PRESS RELEASE published on 06/14/2023 at 17:00, 1 year 5 months ago Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
PRESS RELEASE published on 06/13/2023 at 15:15, 1 year 5 months ago Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit
PRESS RELEASE published on 05/15/2023 at 07:30, 1 year 6 months ago Dermapharm Holding SE: outstanding start to financial year 2023
PRESS RELEASE published on 03/28/2023 at 07:29, 1 year 7 months ago Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
PRESS RELEASE published on 03/22/2023 at 11:00, 1 year 7 months ago EQS-Adhoc: Dermapharm Holding SE: 2022 dividend
PRESS RELEASE published on 03/14/2023 at 07:30, 1 year 8 months ago Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
PRESS RELEASE published on 01/05/2023 at 15:17, 1 year 10 months ago Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
Published on 11/21/2024 at 13:00, 18 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 18 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 18 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 18 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 18 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 43 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 3 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 11:30, 1 hour 48 minutes ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 06:58, 6 hours 20 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 20 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 20 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 17 hours 11 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 58 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
